The T cell immunoglobulin mucin (Tim) family of receptors regulates effector CD4 + T cell functions and is implicated in autoimmune and allergic diseases. Tim-3 induces immunological tolerance, and engagement of the Tim-3 immunoglobulin variable (IgV) domain by galectin-9 is important for appropriate termination of T helper 1-immune responses. The 2 Å crystal structure of the Tim-3 IgV domain demonstrated that four cysteines, which are invariant within the Tim family, form two noncanonical disulfide bonds, resulting in a surface not present in other immunoglobulin superfamily members. Biochemical and biophysical studies demonstrated that this unique structural feature mediates a previously unidentified galectin-9-independent binding process and suggested that this structural feature is conserved within the entire Tim family. The current work provided a graphic example of the relationship between sequence, structure, and function and suggested that the interplay between multiple Tim-3-binding activities contributes to the regulated assembly of signaling complexes required for effective Th1-mediated immunity.
INTRODUCTION
The T cell immunoglobulin mucin (Tim) family (also known as the TIM family) of cell-surface receptors regulates Th1-and Th2-mediated immunity and is implicated in a wide range of autoimmune and allergic diseases, including asthma and rheumatoid arthritis (Meyers et al., 2005b) . The Tim-family genes are tightly clustered and encode eight members in mice (Tim-1 through Tim-8 [also known as mTIM-1 through mTIM-8]) and three members in humans 3, 4 [also known as TIM-1, 3, 4]). All Timfamily proteins share a common architecture, in which the extracellular region possesses a single membrane distal immunoglobulin variable (IgV) domain and a membraneproximal mucin domain of varying length. Notably, the Timfamily IgV domains possess six invariant cysteines. Two of these are predicted to form the hallmark disulfide bond connecting the B and F strands in almost all immunoglobulin superfamily (IgSF) domains, although the structural and functional roles of the remaining four cysteines are unclear. The cytoplasmic domains of Tim family members consist of 42-77 amino acids and, with the exception of Tim-4, are all predicted to bear a conserved tyrosinebased signaling motif. The chromosomal localization, overall sequence conservation, and shared domain organization support the hypothesis that the Tim-family receptors arose from an ancestral gene via successive gene duplication events.
The murine Tim-family genes were positionally cloned from the locus associated with susceptibility to airway hyperresponsiveness (AHR), a mouse model of human asthma (McIntire et al., 2001) . Tim-family proteins exhibit extensive polymorphisms that have been repeatedly associated with various autoimmune and allergic diseases in both humans and mice (Meyers et al., 2005b) . Recently, the Tim-family receptors have also emerged as important regulators of effector CD4 + T cell functions. Tim-1 is preferentially expressed on Th2 cells, whereas Tim-4 is expressed on antigen-presenting cells (APCs) and represents the only natural ligand reported for Tim-1 (Meyers et al., 2005a) . The Tim-1-Tim-4 pathway appears to positively regulate CD4 + T cell activity, as indicated by the fact that an agonistic monoclonal anti-Tim-1 and Tim-4.Ig fusion protein stimulate both T cell proliferation and cytokine production (Meyers et al., 2005a; Umetsu et al., 2005) . In contrast, signaling through Tim-2 has been suggested to impede Th2-mediated immunity, because blockade of Tim-2 by Tim-2.Ig treatment enhances Th2-prototypic cytokine secretion and ameliorates Th1-mediated experimental autoimmune encephalomyelitis (EAE) (Chakravarti et al., 2005) . Tim-2-deficient mice have provided additional evidence to support this notion (Rennert et al., 2006) . These animals exhibit exacerbated atopic lung inflammation upon antigen challenge and enhanced expression of Th2 cytokines during immune responses compared to wild-type mice. Tim-3 was initially cloned as a Th1-specific cell-surface marker and represents the first Tim family member implicated in immune regulation (Monney et al., 2002) . Administration of Tim-3 antibody during the course of EAE augments the disease, resulting in increased mortality and an atypical hyperacute EAE (Monney et al., 2002) . Subsequent studies have demonstrated that Tim-3 inhibits Th1-mediated immunity and promotes peripheral tolerance Sanchez-Fueyo et al., 2003) . The importance of Tim-3 in immune regulation is further underscored by the finding that T cell clones isolated from human multiple sclerosis (MS) patients express lower amounts of Tim-3 and secrete higher amounts of IFN-g than do T cell clones from healthy controls (Koguchi et al., 2006) . These observations suggest that the failure to upregulate Tim-3 at sites of inflammation contributes to the pathogenesis of MS and potentially other autoimmune diseases (Koguchi et al., 2006) . Recent work also suggests a role for Tim-3 in innate immunity. A single treatment with anti-Tim-3 at the very early stages of coxsackievirus (CVB)3 infection, a period when innate immune responses are elicited, exacerbates heart inflammation, probably by reducing CTLA-4 and B7.1 expression on T cells and APCs, respectively (Frisancho-Kiss et al., 2006) . Galectin-9 was recently identified as a Tim-3 ligand that specifically recognizes carbohydrate motif(s) on Tim-3 IgV (Zhu et al., 2005) . Notably, engagement of Tim-3 by galectin-9 promotes calcium fluxes in, and selectively induces apoptosis of, Th1 cells (Zhu et al., 2005) . Furthermore, the in vivo administration of recombinant galectin-9 during an immune response results in selective deletion of IFN-gproducing cells and amelioration of autoimmune disease. Taken together, these observations suggest that the Tim-3-galectin-9 pathway plays an important role in the termination of a productive Th1-immune response, thereby preventing pathological consequences resulting from prolonged and uncontrolled Th1-mediated inflammation .
Despite the important roles of the Tim family in regulating effector CD4 + T cell functions, there are no data addressing the contributions of the unique primary sequence features to structure, ligand recognition, and immune regulation. The crystal structure of the murine Tim-3 IgV domain showed that the four noncanonical cysteines form two unique disulfide bonds, which place the CC 0 and FG loops in close proximity. The surface formed by these loops is not present in other IgSF members, and mutagenesis studies demonstrated that this surface contributes to the recognition of a non-galectin-9 ligand(s) that is present on a wide range of primary immune cells and established cell lines. Additional biochemical and biophysical studies suggested that the unique structural features observed in Tim-3 are conserved within the entire Tim family of immune regulatory receptors. The current work provided a graphic example of the relationship between sequence, structure, and function and highlighted the complex Tim-3-associated regulatory mechanisms that involve multiple ligand-binding interactions.
RESULTS

Tim-3 IgV Domain Exists as a Monomer in Solution
Given the importance of oligomeric state in determining the signaling mechanisms of cell-surface receptors, the solution behavior of the Tim-3 IgV domain was examined. The IgV domain of Tim-3 migrated as a single monodisperse peak on a calibrated Superdex G75 column (30 3 1 cm); the elution volume of $14.9 ml was consistent with the molecular weight of the monomeric Tim-3 IgV domain ( Figure 1A ).
To further address the oligomeric state of Tim-3, sedimentation velocity analysis was performed. Data were collected at four different loading concentrations, ranging from 0.15 to 1.51 mg/ml, and analyzed with the program DcDt+ ( Figure 1B ; Philo, 2000 Philo, , 2006 . The observation that the normalized g(s*) plots for all four concentrations superimpose is strong evidence that, over the concentration range examined, no reversible interactions were occurring. Each of the g(s*) data sets was fit to the model of a single, ideal species by DcDt+ (Philo, 2000 (Philo, , 2006 . The experimentally determined molecular weight was 12.3 ± 0.2 kDa. The four data sets were also fit globally to the model of a single, ideal species with the program Sedphat (Schuck, 2003) . The fitted value for the molecular weight, by Sedphat, was 12.6 ± 0.1 kDa. These results are in very good agreement with the expected molecular weight of the Tim-3 IgV monomer (12.4 kDa), demonstrating that the murine Tim-3 IgV domain exists as a monomer in solution.
The Overall Structure of the Murine Tim-3 IgV Domain The IgV domain of Tim-3 exhibits a two-layered b sandwich with the front and back faces formed by the A 0 , G, F, C, C 0 , C 00 and B, E, D strands, respectively ( Figure 2A ; Table 1 ). The Tim-3 IgV domain exhibits several features common to other IgSF domains (Bork et al., 1994) . The hallmark disulfide bond that connects the B and F strands in most IgSF members is present in Tim-3 (Cys-38-Cys-111); this disulfide bond tethers the front and back sheets and is thought to stabilize the IgV domain (Proba et al., 1997) . The Tim-3 IgV domain is further stabilized by two
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Unique Ligand-Binding Surface of Tim-3 hydrogen bonds present in almost all other IgSF domains: (1) an intersheet hydrogen bond formed by Trp-53 NE2 in the middle of the C strand and the main-chain oxygen of Val-94 at the beginning of the E strand, and (2) a hydrogen bond formed by Tyr-109 OH in the F strand and the mainchain oxygen of Asp-105 preceding the F strand. Moreover, a salt bridge is formed by Arg-82 and Asp-105 preceding the D and F strands, respectively; this ionic interaction is a common feature in other IgSF domains.
Despite sharing overall structural similarities with other canonical IgV domains, the Tim-3 IgV domain exhibits unique features that may be characteristic of the entire Tim family. Most notably, in addition to the hallmark intersheet disulfide bond, Tim-3 possesses two disulfide bonds formed by the four noncanonical cysteines that are invariant within the family. These disulfide bonds direct a unique modification to the well-known immunoglobulin module. In classical IgV domains, the CC 0 and FG loops are located at opposite ends of the domain and are separated by $25 Å . However, as the consequence of these unique disulfide bonds, the CC 0 loop is reoriented and constrained to lie in close proximity to the FG loop, resulting in the formation of a unique ''cleft'' in Tim-3 and a small associated channel with approximate dimensions of 7.5 3 9.5 3 11.0 Å 3 . Furthermore, analogous to the IgV domains present in the CD2 family of receptors, the IgV domain of Tim-3 lacks the A strand that forms back sheet hydrogen bonds with the B strand in typical IgV domains.
The cleft formed by the CC 0 and FG loops is stabilized by the two noncanonical disulfide bonds, as well as a series of conserved ionic and hydrogen bonding interactions (Figure 2A) . Specifically, Cys-58 and Cys-63 located in the CC 0 loop form disulfide bonds with Cys-110 and Cys-52 residing at the F and C strands, respectively, and provide the covalent framework that supports this unique structural feature. The detailed organization of the loop is stabilized by an ionic interaction involving Arg-112 and Asp-121, as well as potential hydrogen bonds involving the side chain of Arg-112 and the main-chain oxygen atoms of Pro-59, Trp-60, and Gln-62. These observations suggest that the primary sequence features present in Tim-3 directs the formation of unique surface that may be involved in the biological function of Tim-3.
The Tim-3 IgV Cleft Is a Galectin-9-Independent Ligand-Binding Surface Of particular interest was the observation that tetramers of bacterially expressed Tim-3 IgV, which lack any form of carbohydrate modification, bound to all primary immune cell types examined, including CD4 + and CD8 + T cells, regulatory T cells, B cells, dendritic cells, and macrophages ( Figures 3A-3E ). Treatment of macrophages with either IFN-g and LPS or IL-4 alone had negligible effect on the Tim-3 ligand expression ( Figure 3E ). However, these treatments induced PD-L1 and PD-L2 expression, respectively, as expected for normal macrophages (data not shown). Interestingly, the Tim-3 tetramer also recognized a ligand(s) expressed on cell lines derived from humans, mouse, and Chinese hamster, including the Jurkat, RMA-S lymphoma cell line ( Figure 3F ), the 3T3 fibroblast cell line, and the CHO cell line ( Figure S1 in the Supplemental Data available online). The lack of glycans precludes interaction with galectin-9 (Zhu et al., 2005) and indicates that Tim-3 IgV recognizes a widely expressed and evolutionarily conserved ligand(s), other than galectin-9, and that this interaction does not involve Tim-3 carbohydrate moieties. Of particular importance, the bacterially expressed tetramer of Tim-3 IgV competed with an Fc fusion protein that includes the full-length ectodomain of Tim-3 for cell-surface binding, demonstrating the specificity of the interaction between the Tim-3 tetramer and the non-galectin-9 ligand(s) ( Figure 3F ).
The unique CC 0 -FG cleft identified in Tim-3 IgV domain is not present in other IgSF domains, suggesting that it may serve some important biological functions, e.g., ligand recognition. To test this idea, a series of Tim-3 IgV mutants (P50A, P50F, Q62A, Q62F, R69F, N74A, R112A, and D121A) and the wild-type Tim-3 IgV domain were transiently expressed in HEK 293T cells as secreted Fc fusion proteins (Tim-3.Ig), and the resulting supernatant was tested for binding by flow cytometry experiments. In addition, purified wild-type, P50F, Q62F, and R112A Tim-3.Ig proteins were also used for binding studies. With the Immunity Unique Ligand-Binding Surface of Tim-3 exception of Asn-74, which resides on the C 0 C 00 loop, other mutated residues are all located in proximity to the cleft.
Similar to bacterially produced Tim-3 tetramer, supernatant containing wild-type Tim-3.Ig recognized a putative ligand(s) on the surface of 3T3 cells. As expected, N74A, which resides outside the cleft, exhibited wild-type binding capability. However, all other mutants (P50A, P50F, Q62A, Q62F, R69F, R112A, and D121A) abolished or diminished binding capability compared to wild-type protein ( Figure 3G ). Consistent with the supernatant result, purified P50F, Q62F, and R112A Tim-3.Ig proteins exhibited weaker or abolished binding to both 3T3 cells and naive CD4 + T cells (data not shown). Furthermore, tetramers of bacterially expressed P50A, P50F, R69F, R112A, and D121A also displayed weaker or abolished binding to both 3T3 and Th1-differentiated DO.11 cells (data not shown). Taken together, these studies strongly suggest that the CC 0 -FG cleft on Tim-3 contributes to a unique galectin-9-independent ligand-binding surface.
Mapping of potential N-and O-linked glycosylation sites onto the Tim-3 structure demonstrates that the CC 0 -FG cleft and its neighboring regions are free of glycans ( Figure 4A ). Given that the Tim-3-galectin-9 interaction absolutely requires glycans on the Tim-3 IgV domain, this distribution suggests that the CC 0 -FG cleft on Tim-3 is unlikely to contribute to the galectin-9 recognition surface. More importantly, based on their location, these glycans are not expected to influence the galectin-9-independent cleft-mediated interactions. Moreover, seven polymorphic residues in murine Tim-3 are all located distal from the cleft ( Figure 4B ) and are not expected to directly affect the binding of Tim-3 to the non-galectin-9 ligand(s) (see below). Taken together, these observations support the existence of two independent Tim-3 ligands and suggest that signaling through Tim-3 requires the integration of multiple signaling pathways.
The Unique Cleft Present in Tim-3 Is a Common Feature of the Tim Family It is of great interest that the N-terminal IgV domain of all Tim family members possesses the equivalents of Cys-52, Cys-58, Cys-63, and Cys-110, which form two noncanonical intramolecular disulfide bonds that promote the unique cleft in Tim-3 ( Figure 2B ). To examine whether the unusual intramolecular disulfide-bonding pattern was a common feature of the entire Tim family, several family members (Tim-1, Tim-3, and Tim-4) were expressed in different hosts and analyzed by SDS-PAGE. Each construct migrated at similar rates under reducing and nonreducing conditions, demonstrating that, as observed in Tim-3, the four additional cysteines do not participate in intermolecular disulfide bonds ( Figure 5A ).
To further address the potential structural contribution of these invariant cysteines within the Tim family, the number of disulfide bonds in the IgV domain of murine Tim-1 was determined by electrospray ionization-Fourier transform-ion cyclotron resonance-mass spectrometry (ESI-FT-ICR-MS); formation of three disulfide bonds in Tim-1 will result in loss of six hydrogen atoms and a decrease in mass of six Daltons compared to the same protein with six free cysteines. The murine Tim-1 IgV domain fused to the Fc of a murine IgG2a with an intervening thrombin protease site was expressed in HEK 293T cells. After cleavage, the resultant protein yielded an experimentally determined molecular weight of 12839.38 Daltons, as compared to the theoretical molecular weight of 12839.4 Daltons with three disulfide bonds. Similarly, murine Tim-1 IgV domain with a C-terminal six-histidine tag was also expressed in S2 cells and yielded a molecular weight of 13470.65 Daltons, as compared to the theoretical molecular weight of 13471.0 Daltons with three disulfide bonds ( Figure 5B ). These analyses demonstrated that murine Tim-1 IgV domain expressed in eukaryotic hosts possesses three intramolecular disulfide bonds and suggested that the noncanonical disulfide bonds and the associated CC 0 -FG ligand-binding cleft present in the Tim-3 are common features of all Tim family members.
DISCUSSION
The structural features present in the IgSF support a remarkably diverse range of biological functions (Halaby and Mornon, 1998) . Based on its overall b strand topology, the N-terminal domain of murine Tim-3 can be readily assigned to the V set; however, two noncanonical disulfide bonds direct a reorganization of this basis fold and the formation of a unique ligand-binding surface. A particular concern is that the noncanonical disulfide bonds observed in Tim-3 are the consequence of the oxidative refolding protocol applied to the E. coli-expressed material. However, the observation that bacterially expressed Tim-3 tetramer competed with Tim-3.Ig for binding to a nongalectin-9 ligand(s) is strong evidence that the current structure is physiologically relevant. It is notable that the four noncanonical cysteine residues are completely invariant in all known Tim family members, and direct biochemical and biophysical analyses indicated that the unique covalent structure observed in the CC 0 -FG cleft of Tim-3 is a feature of the entire Tim family, lending additional support to the current Tim-3 structure. Furthermore, Arg-112 and Asp-121 are nearly invariant, suggesting that the ionic and hydrogen-binding interactions observed in Tim-3 are of widespread importance in the family. In 
where Fo and Fc are observed and calculated structure factors, respectively. d Parentheses indicate statistics for the high-resolution data bin for x-ray and refinement data.
contrast, Pro-59, Trp-60, and Gln-62, which form potential hydrogen bonds with the side chain of Arg-112 in Tim-3, are not conserved within the Tim family. However, these three residues contribute invariant main-chain oxygen atoms as potential hydrogen bond acceptors, and sidechain alterations are not predicted to significantly perturb these putative interactions. It is likely that these hydrogen bonds are locally conserved throughout the Tim family. The only exception to this generality is murine Tim-2, where Arg-112 and Asp-121 are replaced by valine and phenylalanine, respectively; modeling suggests that these residues could form productive van der Waals interactions that may in part compensate for the lack of the ionic interaction. Furthermore, the length of the CC 0 loop is predicted to be the same in all members of the Tim family of receptors, suggesting that the analogous loop in other Tim-family receptors may adopt a conformation similar to that observed in Tim-3.
The sequence and putative structural conservation suggest that the surfaces formed by the CC 0 and FG loops are likely to be relevant to biological function. Our mutagenesis studies strongly suggest that this CC 0 -FG cleft is a potential ligand-binding surface, because alterations of residues in this region resulted in abolished or reduced binding of eukaryotically expressed murine Tim-3.Ig to the surfaces of 3T3 cells ( Figure 3G ) and naive murine CD4 + T cells (data not shown). Murine Tim-3 possesses two potential N-linked glycans (Asn-74 and Asn-100) and one putative O-glycan (Thr-44), all of which are distal to the CC 0 -FG surface and are thus not expected to impact potential interactions involving this surface. It has recently been reported that, via its N-and/or O-glycans, the murine Tim-3 IgV domain is sufficient to support binding to galectin-9 and that this interaction is critical for inducing apoptosis of Th1 CD4 + T cells and termination of a productive Th1-mediated inflammatory immune response (Zhu et al., 2005) . The Tim-3 IgV structure shows that these potential glycans and the CC 0 -FG surface are widely separated, and thus suggests that the cell-surface binding activity associated with the CC 0 -FG surface is distinct from the galectin-9-associated interaction. This notion is supported by the observation that bacterially expressed Tim-3 tetramer, which lacks all forms of glycans, nonetheless binds to the surfaces of a wide range of primary immune cells (CD4 + , CD8 + , regulatory T cells, B cells, macrophages, and dendritic cells) and established cell lines (3T3, RMA-S, Jurkat, Ramos, and others). Taken together, these observations suggest a complex mechanism for Tim-3 signaling that involves both galectin-9-dependent and galectin-9-independent binding interactions. Although the cell-surface ligand(s) recognized by the CC 0 -FG cleft has not been identified, the observation of the small channel is intriguing. It is conceivable that this feature may contribute to local structural or dynamic changes associated with the recognition of protein and/or carbohydrate epitopes present on cell-surface target molecules.
Polymorphisms in the Tim family have been linked to susceptibility to autoimmune and allergic diseases in both humans and mice. Most notably, susceptible BALB/c and resistant DBA/2 mouse strains exhibit seven polymorphic residues in Tim-3, i.e., are in BALB/c strain, whereas Asn-24, Ala-25, Val-27, Phe-28, Ser-43, Pro-45, and Ala-47 are present in DBA/2 strain. All of these residues are clustered on the IgV domain of murine Tim-3 (McIntire et al., 2001) . Based on the Tim-3 IgV structure, these polymorphisms all map to the A 0 strand and the BC loop and are distal to the potential ligand-recognition surface formed by the CC 0 and FG loops. Taken together, these observations suggest that the polymorphisms of murine Tim-3 are not likely to directly affect ligand recognition activity associated with the CC 0 -FG cleft. However, it is notable that the polymorphisms at the BC loop are very close to the putative O-glycosylation site (Thr-44) on murine Tim-3 IgV domain and could potentially affect the interaction between murine Tim-3 and galectin-9.
All of the murine Tim-3 polymorphic residues are highly solvent exposed with the exception of the partially buried Val-28. In DBA/2 mice, Val-28 is replaced by a phenylalanine, and modeling suggests that this substitution can be accommodated without altering the overall structure of Tim-3. Therefore, the polymorphisms of murine Tim-3 are not expected to dramatically affect the global structure, although they could influence the overall stability of the molecule. Alternatively, several polymorphisms (Asp-24, Gly-25, Lys-27, and Val-28) are clustered near the IgV-mucin junction, so they could modulate the interactions between these domains and thus influence the disposition of the IgV domain and the ligand-recognition surfaces with respect to the mucin domain and the plasma membrane. Such alteration in the overall organization of the Tim-3 molecule could affect the presentation of its ligand-binding surface and thus impact its signaling capability.
The present work demonstrated that the IgV domain of Tim-3 exists as a monomer in solution and in the crystalline state. Similarly, our biochemical and biophysical analyses indicate that covalent disulfide bond-driven dimerization is absent from the entire Tim family. However, it remains a possibility that for Tim-1, Tim-2, and Tim-4, other binding mechanisms involving the IgV domains might contribute to noncovalent dimerization. Furthermore, all Tim-family receptors possess a highly O-glycosylated mucin domain whose function is poorly understood, and it is conceivable that these domains might contribute to the overall oligomeric state on the cell surface. In support of noncovalent dimerization of Tim-1 and Tim-2, recent studies revealed that both Tim-1 and Tim-2 were capable of transmitting signals in a crosslinking-independent manner (de Souza et al., 2005; Knickelbein et al., 2006) . Specifically, ectopic expression of Tim-1 provides a stimulatory signal that results in IL-4 transcription in the D10 T cells or the Jurkat cell line in the absence of crosslinking of the receptors (de Souza , 2006) . Moreover, the administration of Tim-1.Ig fusion protein has negligible effect on the activation of Jurkat T cells transiently transfected with Tim-1, suggesting that the stimulatory effect of Tim-1 does not result from the engagement of Tim-1 by an independent ligand (de Souza et al., 2005) . Taken together, these data suggest a model in which homodimerization of Tim-1 and Tim-2 may be sufficient for the activation of these receptors. This ligand-independent signaling is reminiscent of CD45 activation, which is regulated by homodimerization that is in turn controlled by the extent of glycosylation of its ectodomain (Xu and Weiss, 2002) .
Tim-3 appears to possess both galectin-9-dependent and galectin-9-independent binding activities. The ubiquitously expressed galectin-9 selectively induces apoptosis of Th1 cells and resolves inflammation by engaging Tim-3 (Zhu et al., 2005) . Our study demonstrated the existence of a second widely distributed non-galectin-9 ligand(s) for murine Tim-3. Although the identity of this unique ligand(s) remains to be elucidated, the existence of two widely expressed ligands for the same Tim-3 receptor could provide an additional layer of regulation for Th1-mediated immunity. Galectin-9 is composed of two nonidentical carbohydrate recognition domains (CRDs), both of which are capable of recognizing Tim-3 (Zhu et al., 2005) . Moreover, a recent study demonstrated that the N-terminal CRD of galectin-9 exists as a dimer (Nagae et al., 2006) , suggesting that galectin-9 could potentially crosslink multiple Tim-3 molecules. Furthermore, the existence of a galectin-9-independent binding activity offers a mechanism for the recruitment of distinct protein species and the localized assembly of multicomponent signaling complexes. Intriguingly, the non-galectin-9 ligand(s) is expressed on a wide range of tumor and transformed cell lines. The non-galectin-9 ligand(s) on tumor cells could potentially inhibit immune responses directed against them, and thus provides a mechanism for immune evasion. This observation suggests that the Tim-3/Tim-3 ligand pathway represents a potential target for the development of cancer immunotherapy.
In summary, the Tim family represents a remarkable example of the connection between primary amino acid sequence, three-dimensional structure, and biological function. Two noncanonical disulfides in Tim-3 direct the formation of a unique binding surface that supports interactions with a ligand that is distinct from galectin-9. The complex interplay between the multiple ligand-binding activities of Tim-3 will likely contribute to the regulated assembly of signaling complexes required for the modulation of Th1-mediated immunity.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of the IgV Domain of Murine Tim-3 The Tim-3 IgV domain from the BALB/c strain (24-131 plus the initiator methionine) was expressed as inclusion bodies from pET-3a in the Rosetta (DE3) pLysS E. coli strain. Inclusion bodies were purified and refolded as described for B7.2 with slight modification (Zhang et al., 2002) . The refolding buffer is composed of 0.4 M Arginine-HCl, 200 mM Tris (pH 9.0), 2 mM EDTA, 5 mM cysteamine, and 0.5 mM cystamine. Protein was purified by gel filtration and cation exchange chromatography.
Sedimentation Velocity Analysis
The Tim-3 IgV domain was exchanged into buffer composed of 20 mM Tris (pH 7.45), 50 mM NaCl. Sedimentation velocity analysis was performed at protein concentrations of 1.51, 1.12, 0.33, and 0.15 mg/ ml in a Beckman Coulter XL-I. Interference scans were acquired at 1 min intervals for 7 hr at 20 C and 55,000 rpm. Data sets were individually analyzed with the program DcDt+ (Philo, 2000 (Philo, , 2006 . The individual g(s*) data sets were fit to the model of a single, ideal species by DcDt+ (Philo, 2000 (Philo, , 2006 . In addition, the data sets were fit globally to the model of a single, ideal species by the direct boundary modeling program Sedphat (Schuck, 2003) , which allows the user to fit the data to various association schemes with multiple data sets, as well as individual data sets.
Crystallization, Data Collection, and Structure Determination Tim-3 protein (25 mg/ml in 10 mM MES [pH 6.0]) was crystallized by hanging drop diffusion with 2 ml of protein and 2 ml of buffer composed of 1.8-1.9 M (NH 4 ) 2 SO 4 , 100 mM sodium citrate buffer (pH 4.9-5.2) at 18 C. Crystals were flash cooled in mother liquor supplemented with 20% PEG400 and exhibited diffraction consistent with the space group P2 1 . Data were collected to 1.9 Å resolution at beam line X29 of the National Synchrotron Light Source, Brookhaven National Laboratory. Data were integrated and scaled with HKL2000 (Otwinowski and Minor, 1997) . The Tim-3 IgV structure was solved by molecular replacement with the program MOLREP (Vagin and Teplyakov, 2000) implemented in CCP4 suite (CCP4, 1994) . The search model contained residues 25-46, 50-84, and 101-139 from the coxsackievirus and adenovirus receptor D1 domain (PDB accession number: 1EAJ). 2Fo À Fc and Fo À Fc maps were used to manually revise the model and to build missing parts of the structure. This model was subjected to simulated annealing with CNS to remove possible model bias (Brunger et al., 1998) . ARP/ wARP was used to build the majority of the molecule, and the model was manually revised by COOT (Emsley and Cowtan, 2004) and further refined by the program REFMAC5 (Murshudov et al., 1997 ). The final model contains all residues present in the construct (24-131 plus the initiator methionine), 103 water molecules, and 1 sulfate ion, with R work and R free of 15.6% and 20%, respectively. Data collection, phasing, and model refinement statistics are tabulated in Table 1 .
Soluble Form of Wild-Type and Mutant Tim-3 Proteins DNA encoding the IgV domain (1-132) of wild-type or mutant (P50A, P50F, Q62A, Q62F, R69F, N74A, R112A, and D121A) murine Tim-3 was fused in-frame upstream of the murine IgG2a Fc region. To facilitate protein purification, a six-histidine tag was engineered at the C terminus of the Fc region. Fc fusion constructs were cloned onto the pIRES2-EGFP vector, and the resultant plasmids were transfected into HEK 293T cells. Culture supernatants were harvested 48 hr after transfection and were used as a source for Fc fusion proteins. Wildtype, P50F, Q62F, and R112A constructs were also used to transfect 600 ml 293F cells suspension culture with 293fectin (Invitrogen) according to the manufacturer's instructions, and Fc fusion proteins were purified by Ni-NTA chromatography. Both purified Fc fusion proteins and Fc fusion proteins in culture supernatant were quantified by ELISA, and equivalent amounts of fusion protein were used in flow cytometry experiments.
Expression of Murine Tim-1 in S2 and HEK 293T Cells A DNA fragment encoding the IgV domain of murine Tim-1 (21-130) was cloned into pMT/BiP/V5-His vector (Invitrogen) between the BglII and AgeI restriction sites. The resultant plasmid and pCoBlast (20:1 ratio) were used to cotransfect S2 cells with Ca 3 (PO 4 ) 2 (Invitrogen) according to the manufacturer's instructions. Blasticidin-resistant cells were selected for 2 weeks with Schneider's Drosophila medium supplemented with 10% heat-inactivated FBS and 25 mg/ml blasticidin. The resultant recombinant Tim-1 protein contains 10 extra residues encoded by the vector sequence, i.e., two residues (RS) and eight residues (TGHHHHHH) at the N and C termini, respectively.
For large-scale production of soluble Tim-1 IgV, stably transfected S2 cells were cultured in EX-Cell 420 (SAFC Biosciences) supplemented with 50 mg/ml gentamycin and 6.8 mM glutamine at 28 C.
Expression was induced with 0.8 mM CuSO 4 at a density of 8-10 3 10 6 cells/ml, and the culture was grown for 3 days under the same conditions. Cells were removed by centrifugation at 200 3 g, 4 C for 10 min, and the supernatant was further clarified by centrifugation at 5000 3 g, 4 C for 20 min. The supernatant was passed through a 0.22 mm filter, concentrated, and exchanged into a buffer composed of 50 mM HEPES, 150 mM NaCl (pH 7.5). This material was clarified by centrifugation at 5000 3 g, 4 C for 20 min and passed through a 0.22 mm filter.
The protein solution was supplemented with 10% glycerol and 10 mM imidazole and purified by Ni-NTA chromatography. Eluted proteins were concentrated and further purified by gel filtration chromatography. DNA encoding the IgV domain of murine Tim-1 (1-130) was cloned into a modified pIRES2-EGFP vector. This cloning strategy resulted in secretion of a protein with the following linear arrangement: Tim-1 (22-130)-VD-LVPRGS (thrombin cleavage site)-GGS-mIgG2a Fc-HHHHHH. Cell lines stably expressing Tim-1.Ig were obtained by selecting GFP-positive cells. For large-scale Tim-1.Ig fusion protein production, transfectants were cultured in Freestyle 293 medium (Invitrogen) according to the manufacturer's instructions. Cells were removed by centrifugation at 5000 3 g, the supernatant was concentrated and supplemented with 10% glycerol and 10 mM imidazole, and the protein was purified by Ni-NTA chromatography. The protein was digested with thrombin at room temperature for 6 hr, and the resultant Tim-1 protein (22-130 plus VDLVPR) was further purified by anion ion exchange chromatography prior to FT-ICR mass spectrometry.
Flow Cytometry
Tim-3 IgV domain (22-132) with a BirA recognition site (GLNDIFEAQ-KIEWHE) fused immediately at its C terminus was expressed, refolded from inclusion bodies, and purified as described above for native . Purified protein was biotinylated in vitro with BirA (Avidity, LLC). The resulting protein was multimerized with PE-conjugated streptavidin (Prozyme) in a 4:1 molar ratio and purified on a Superdex 200 gel filtration column.
After incubation with 24G2 antibody to block the Fc receptor, cells from lymph nodes and spleens of C57BL/6 mice were incubated with Tim-3 tetramer or control (OVA-H-2K b tetramer or PE-streptavidin) and antibodies that recognize either CD4, CD8, Foxp3, B220, or CD11c+, which are specific markers of CD4 + , CD8 + , regulatory T cells, B cells, and dendritic cells, respectively. For macrophage staining, C57BL/6 mice were injected with 2-4 ml of 4% thioglycolate, and peritoneal cavity cells were harvested 4 days late for ex vivo staining. These cells were also activated either with LPS and IFN-g (100 ng/ml each) or IL-4 (20 ng/ml) for 24 hr before staining. For competition experiment, RMA-S lymphoma cells were incubated with Tim-3 tetramer in the presence of murine Tim-3.Ig (eBioscience) or a control human IgG1 (Sigma), and OVA-H-2K b tetramer was used as a control. For Tim-3.Ig staining, 3T3 cells were incubated with Tim-3.Ig or control B7x.Ig for 30 min on ice, and then with goat anti-mouse IgG-PE for 30 min on ice. The living cells as determined by Propidium Iodide (PI) exclusion were analyzed on a CyAn (DakoCytomation).
SDS-PAGE Analysis
Recombinant murine Tim-1 IgV (expressed in S2 cells), Tim-3 IgV (expressed in E. coli), and the complete ectodomains of murine Tim-1 and Tim-4 (R&D Systems, Inc.) were boiled for 5 min in a loading buffer composed of 40 mM Tris/HCl (pH 6.8), 1% SDS, 5% glycerin, and 0.1% bromphenol, with or without 5% mercaptoethanol. The samples were separated on a 4%-20% PAGE gel (Bio-rad), and the proteins were visualized by staining with coomassie blue.
Mass Spectrometry
The mass of the murine Tim-1 IgV domain, expressed in either HEK 293T cells or S2 cells, was determined by electrospray ionization-fourier transform-ion cyclotron resonance-mass spectrometry. Spectra were acquired on an IonSpec FT-ICR mass spectrometer (Varian Inc., CA) with a 9.4-T actively shielded magnet coupled a Z-spray ESI source. Spectra were calibrated externally with monoisotopic masses from the doubly charged ions of Angiotensin II, Bombesin, Substance P, and the quadruply charged ion of Melittin. The mass spectra were deconvoluted and the average mass were obtained with Omega8 software package. The mass accuracy obtained from this instrument is about ±0.5 Dalton for the Tim-1 IgV domain.
Structure Analysis
Atomic contacts were calculated with contact programs as implemented in the CCP4 suite (CCP4, 1994). Sequence alignment was rendered with the program ESPript (Gouet et al., 1999) . Ribbon diagrams and molecular surface were generated with Pymol (W.L. DeLano, http://pymol.sourceforge.net/). Potential sites of O-glycan modification were predicted with the program NetOGlyc 3.1 Server (Julenius et al., 2005) .
Supplemental Data
One Supplemental Figure can be found with this article online at http:// www.immunity.com/cgi/content/full/26/3/311/DC1/.
